ELOC and hepatocellular carcinoma: For instance, CUL2, RBX1, ELOB, and ELOC are known to interact with PRAME, a substrate-recognition subunit that is overexpressed in a variety of cancers, including HCC (Costessi et al., 2011; Zhu et al., 2018).